Browse studies

Find your next paid study

26,753 recruiting studies available now

Recharge Behavioral Therapy for Caregivers of Individuals With Alzheimer's Disease

This project will evaluate the effectiveness of the Recharge Behavioral Therapy (RBT) intervention to alleviate stress and depressive symptoms of caregivers of…

Caregiver Stress

Estimated

~$10 – $8,750

Photozig, Inc.NCT07764185

Phase 3

Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial

The aims of this clinical trial will test whether or not the onset of nearsightedness is delayed in a group of children randomized to nightly drops in 0.05% at…

Myopia

Estimated

~$10 – $6,250

Ohio State UniversityNCT07567040

Phase 3

A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Growth Hormone Deficiency (GHD)

The OraGrowtH Phase 3 Trial is a multi-national trial. The goals of the trial are to study LUM-201 as a treatment for Pediatric Growth Hormone Deficiency (PGHD…

Growth Hormone Deficiency (GHD)

Estimated

~$10 – $8,750

Lumos PharmaNCT06948214

Observational

Blood Flow Restriction Training After Patellar INStability (BRAINS Trial)

This research study is designed to allow health care professionals and researchers to answer many questions about whether a new type of physical therapy called…

Patellar DislocationKnee InjuriesLeg Injury+1 more

Estimated

~$10 – $7,500

Caitlin ConleyNCT04554212

Phase 2

A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis (ATUNE)

The goal of this study is to find out if a medication called upadacitinib can help treat a condition called Eosinophilic Esophagitis (EoE). The main question …

EoEEosinophilic EsophagitisEosinophilic Esophagitis (EoE)

Estimated

~$10 – $6,250

University of North Carolina, Chapel HillNCT07588568

Women's Ischemia Syndrome Evaluation (WISE) - Coronary Microvascular Dysfunction (CMD) and Heart Failure With Preserved Ejection Fraction (HFpEF)

The Women's Ischemia Study Evaluation (WISE), a cohort study of over 1000 women, has made many contributions to the understanding of cardiovascular disease. A …

Microvascular Coronary DysfunctionCardiovascular Disease

Estimated

~$10 – $750

Cedars-Sinai Medical CenterNCT02582021

Phase 2

A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Ph-Negative, CD22-Positive B-Lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults With Relapsed or Refractory Disease

This phase II trial studies how well inotuzumab ozogamicin and blinatumomab with or without ponatinib work in treating patients with CD22-positive B-lineage ac…

B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeRecurrent B Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT03739814

Technical and Translational Development of Cardiovascular MRI (CMR)

Background: Magnetic resonance imaging (MRI) is an important non-invasive tool to study and diagnose cardiovascular disease. MRI scanners use strong magnetic …

Normal and Abnormal Cardiovascular Physiology

Estimated

~$10 – $675

National Heart, Lung, and Blood Institute (NHLBI)NCT03581318

Phase 1

A Phase 1/2, Open-Label, Dose-Escalation and -Expansion Study of the Bruton Tyrosine Kinase Targeted Protein Degrader BGB-16673 in Patients With B-Cell Malignancies

Study consists of two main parts to explore tacabrutideg recommended dosing, a Phase 1 monotherapy dose finding comprised of monotherapy dose escalation and mo…

B-cell MalignancyMarginal Zone LymphomaFollicular Lymphoma+6 more

Estimated

~$10 – $7,500

BeOne MedicinesNCT05006716

Phase 3

A Randomized, Double-masked, Active-controlled, Multi-center, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal Tabirafusp Tedromer 5 mg Compared With Intravitreal Aflibercept 2 mg in Participants With Visual Impairment Secondary to Diabetic Macular Edema (DME) - ALTO

A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants with Diabetic Macular Edema - ALTO

Diabetic Macular Edema (DME)

Estimated

~$10 – $8,750

Kodiak Sciences IncNCT07734844

Phase 2

preEMBER: A Phase 2, Open-label Study Evaluating Imlunestrant in Premenopausal Women With Estrogen Receptor-Positive, HER2-Negative Breast Cancer

This study will include two groups of patients: Cohort 1 and Cohort 2. Cohort 1: will help researchers learn how a medicine called imlunestrant (LY3484356) af…

Breast Neoplasms

Estimated

~$10 – $7,500

Eli Lilly and CompanyNCT07287098

Observational

Buprenorphine Implementation at Syringe Services Programs To Reduce Overdoses: A Type 1 Hybrid Effectiveness-Implementation Trial

This study is testing whether offering buprenorphine treatment directly at syringe service programs (SSPs) helps more people start and stay in treatment for op…

Opioid Use DisorderOpioid Use Disorder, SevereOpioid Use Disorder, Moderate

Estimated

~$10 – $6,250

Montefiore Medical CenterNCT07631598